Martin Fussenegger's ETH Zurich team in Basel built an experimental electronic implant that converts excess glucose into gluconate using a gold-platinum catalyst on graphite felt. In diabetic mice, it regulated blood sugar and the animals lost weight over six weeks, but it has not been tested in humans.